DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

References

Shapiro AD, Ragni MV, Valentino LA , et al.
Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients.

Blood 2012;
119 (3) 666-672

Download Bibliographical Data

Search in:
Access: